Who owns OUTLOOK THERAPEUTICS INC COM?

Tip: Access positions for across all investors

Analyze quarterly positions in Outlook Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Outlook Therapeutics stock

Who bought or sold OUTLOOK THERAPEUTICS INC COM this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Schonfeld Strategic Advisors 2.4M $3.9M 241% Dec 2025
 View chart
Vanguard Capital Management 2.0M $405k 100% Mar 2026
 View chart
Vanguard Group 1.5M $2.3M 9% Dec 2025
 View chart
Sio Capital Management 1.1M $1.8M 100% Dec 2025
 View chart
Citadel Advisors 1.0M $1.6M 2170% Dec 2025
 View chart
Susquehanna International 733k $1.2M 211% Dec 2025
 View chart
Gilpin Wealth Management 710k $146k 100% Mar 2026
 View chart
Commonwealth Equity Services 470k $97k 318% Mar 2026
 View chart
BlackRock 405k $639k 9% Dec 2025
 View chart
Geode Capital Management 317k $500k 3% Dec 2025
 View chart
Marshall Wace 299k $472k 100% Dec 2025
 View chart
Warberg Asset Management 275k $56k 100% Mar 2026
 View chart
Vanguard Fiduciary Trust 177k $36k 100% Mar 2026
 View chart
Millennium Management 165k $260k -15% Dec 2025
 View chart
State Street Corporation 163k $258k 117% Dec 2025
 View chart
Jane Street 162k $256k 301% Dec 2025
 View chart
UBS Group 133k $27k -36% Mar 2026
 View chart
Simplex Trading 106k $167k 19% Dec 2025
 View chart
ADAR1 Capital Management 100k $158k 100% Dec 2025
 View chart
Scotia Capital 74k $117k 0% Dec 2025
 View chart
Northern Trust 67k $107k 159% Dec 2025
 View chart
Goldman Sachs Group 46k $72k 7% Dec 2025
 View chart
Group One Trading 37k $59k 120% Dec 2025
 View chart
LPL Financial 34k $6.9k 54% Mar 2026
 View chart
XTX Topco 30k $48k 175% Dec 2025
 View chart
Christensen, King & Associates Investment Services 28k $5.8k 0% Mar 2026
 View chart
Pnc Financial Services 25k $5.2k 67% Mar 2026
 View chart
Flower City Capital 20k $4.1k 0% Mar 2026
 View chart
JustInvest 16k $25k 12% Dec 2025
 View chart
Oppenheimer & Co 16k $3.2k 100% Mar 2026
 View chart
Tower Research Capital 13k $20k 100% Dec 2025
 View chart
Squarepoint Ops 12k $19k 100% Dec 2025
 View chart
Harbour Investments 10k $16k 1137% Dec 2025
 View chart
Tudor Investment Corporation 10k $16k -60% Dec 2025
 View chart
Advisor Group Holdings 9.0k $14k 0% Dec 2025
 View chart
Vanguard Global Advisers 6.9k $1.4k 100% Mar 2026
 View chart
Fortitude Family Office 2.6k $526.124000 502% Mar 2026
 View chart
Jones Financial Companies, L.L 2.5k $4.0k 0% Dec 2025
 View chart
Wells Fargo & Company 2.5k $3.9k 76% Dec 2025
 View chart
Northwestern Mutual Wealth Management Company 2.3k $472.057600 8% Mar 2026
 View chart
Federation des caisses Desjardins du Quebec 1.3k $2.1k 0% Dec 2025
 View chart
Ancora Advisors 1.1k $1.7k 0% Dec 2025
 View chart
EverSource Wealth Advisors 696.00 $1.1k 0% Dec 2025
 View chart
FMR 606.00 $954.753000 472% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 305.00 $481.991500 0% Dec 2025
 View chart
CWM 283.00 $0 0% Dec 2025
 View chart
SBI Securities 222.00 $45.998400 6% Mar 2026
 View chart
Armstrong Advisory Group 179.00 $36.999300 0% Mar 2026
 View chart
Larson Financial Group 100.00 $158.000000 0% Dec 2025
 View chart
IFP Advisors 50.00 $10.000000 0% Mar 2026
 View chart
Steward Partners Investment Advisory 14.00 $3.000200 0% Mar 2026
 View chart
Bogart Wealth 5.00 $1.000000 100% Mar 2026
 View chart
Barclays 1.00 $2.000000 0% Dec 2025
 View chart

Who sold out of Outlook Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
LVW Advisors Dec 2025 48k $76k
Vontobel Holding Dec 2025 40k $63k
Two Sigma Securities Sep 2025 36k $38k
Qube Research & Technologies Sep 2025 13k $14k
Two Sigma Investments Sep 2025 11k $12k
International Assets Investment Management Dec 2025 1.0k $1.6k
SHP Wealth Management Dec 2025 59.00 $93.001700